MB Venture Partners

MB Venture Partners, established in 2001, is a Tennessee-based venture capital firm headquartered in Memphis. The company specializes in providing equity capital and strategic guidance to life sciences businesses, with a focus on medical device and biotechnology companies at various stages of development. MB Venture Partners is particularly interested in product solutions for musculoskeletal diseases, leveraging its partners' extensive experience and relationships in this field. The firm invests across the Southeast and Midwest regions of the United States.

Larry Papasan

Venture Partner

Past deals in Tennessee

SweetBio

Seed Round in 2018
SweetBio, Inc. is a medical device company based in Memphis, Tennessee, specializing in the research, development, and manufacturing of innovative wound care solutions. Founded in 2015, the company focuses on bioengineering membranes that utilize medical-grade Manuka honey to enhance healing and combat infections associated with wounds, pressure ulcers, diabetic ulcers, surgical wounds, and abrasions. SweetBio's unique honey-incorporated absorbable membranes are designed to improve the efficacy of wound care treatments, offering healthcare professionals a new platform for addressing both chronic and acute wounds effectively.

Cast21

Seed Round in 2017
Cast21 is a medical product developer based in Memphis, Tennessee, focused on creating innovative orthopedic solutions for fracture and joint care. Established in 2015, the company has developed a waterproof and breathable cast designed to enhance patient comfort and facilitate recovery. Its unique design not only allows for skin hygiene—enabling patients to wash and scratch beneath the cast—but also supports the integration of electronic therapies aimed at reducing healing time. By prioritizing user experience and effective treatment, Cast21 seeks to improve the overall recovery process for individuals with orthopedic injuries.

SweetBio

Pre Seed Round in 2015
SweetBio, Inc. is a medical device company based in Memphis, Tennessee, specializing in the research, development, and manufacturing of innovative wound care solutions. Founded in 2015, the company focuses on bioengineering membranes that utilize medical-grade Manuka honey to enhance healing and combat infections associated with wounds, pressure ulcers, diabetic ulcers, surgical wounds, and abrasions. SweetBio's unique honey-incorporated absorbable membranes are designed to improve the efficacy of wound care treatments, offering healthcare professionals a new platform for addressing both chronic and acute wounds effectively.

Restore Medical Solutions

Series A in 2015
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Better Walk

Series A in 2015
Better Walk Inc. is an innovative company that specializes in the design and development of crutches. Established in 2013 and headquartered in Atlanta, Georgia, the company aims to improve traditional crutch technology by alleviating pressure from the underarm area and minimizing direct force on the wrist of users. Better Walk's commitment to innovation is a fundamental aspect of its culture, which was further strengthened during its participation in the Zero To 510 accelerator in Memphis, where it secured early venture funding. In late 2014, the company shifted its focus to finalizing the Better Walk crutch, positioning itself for production and an anticipated product launch in early 2015.

CrossRoads Extremity Systems

Venture Round in 2014
CrossRoads Extremity Systems, LLC is a medical device manufacturing company based in Memphis, Tennessee, specializing in implant systems for foot and ankle surgery. Founded in 2014, the company designs, manufactures, and markets a variety of surgical implants, including the MotoBAND CP Plating System for midfoot and forefoot procedures, the STRoPP implant kit, and the MotoCLIP which provides elastic fixation for healing bones. Additionally, CrossRoads produces the CrossTIE PIP Implant for hammertoe correction, various CrossTIE implant configurations for revision cases, and EcoSMART, an instrument recovery service. The company also develops Allograft wedges for consistent surgical handling, DBM putties, and advanced systems like DynaFORCE and Keel-Lock for enhanced surgical outcomes. CrossRoads Extremity Systems distributes its products through various partners in the United States, aimed at improving the operating room experience and achieving better patient outcomes.

Blood Monitoring Solutions

Seed Round in 2014
Blood Monitoring Solutions, Inc. is dedicated to developing innovative blood monitoring systems aimed at reducing blood wastage. Based in Memphis, Tennessee, the company has created a smart blood transport system that enables blood banks to continuously monitor the temperature and integrity of each blood unit. This proactive, data-driven approach not only enhances patient safety but also helps hospitals minimize costs associated with blood spoilage. By ensuring that blood is stored within the appropriate temperature range, the company's solutions allow for longer preservation of blood supplies, ultimately supporting more effective transfusion practices in healthcare settings.

CamPlex

Seed Round in 2014
CamPlex is a U.S.-based company founded in 2012 and headquartered in Germantown, Tennessee, specializing in the healthcare industry. The company focuses on manufacturing high-quality fiber optic products designed to enhance performance and extend signal transmission capabilities. CamPlex offers innovative fiber optic-based camera adapter systems and broadcast-grade interface gear, which help broadcast professionals streamline signal delivery and improve operational efficiency. By providing these solutions, CamPlex aims to reduce operating costs and eliminate the necessity for additional components and costly replacements.

Tidal Wave Technology

Seed Round in 2014
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Restore Medical Solutions

Series A in 2014
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Hapten Sciences

Venture Round in 2014
Hapten Sciences, Inc. is a privately-held biopharmaceutical company based in Memphis, Tennessee, established in 2010. The company focuses on the identification and development of early-stage products aimed at improving global health outcomes. One of its key innovations is PDC-APB, a vaccine designed to prevent contact dermatitis resulting from exposure to urushiol oil found in poison ivy, poison oak, and poison sumac. This product aims to provide patients with a solution to avoid allergic reactions without side effects, thereby contributing significantly to the well-being of individuals affected by these plants.

iScreen Vision

Series B in 2013
iScreen Vision, Inc. is a medical device company based in Cordova, Tennessee, specializing in pediatric vision screening solutions. Founded in 2009, the company utilizes advanced photoscreening technology to provide a fast and portable method for detecting vision problems in infants, preschool, and school-age children. By offering physicians a patented digital photoscreening device, iScreen Vision enables efficient screening for common childhood vision issues, including those that may lead to amblyopia if not addressed promptly. The company also integrates cloud-based transmission, analysis, and storage of screening images, facilitating seamless coordination with Electronic Medical Records (EMR) systems for healthcare providers.

Focal Point Pharmaceuticals

Seed Round in 2013
Focal Point Pharmaceuticals is a healthcare company focused on pharmaceutical businesses. It was incorporated in 2013 and is based in Memphis, Tennessee, United States.

iScreen Vision

Series B in 2013
iScreen Vision, Inc. is a medical device company based in Cordova, Tennessee, specializing in pediatric vision screening solutions. Founded in 2009, the company utilizes advanced photoscreening technology to provide a fast and portable method for detecting vision problems in infants, preschool, and school-age children. By offering physicians a patented digital photoscreening device, iScreen Vision enables efficient screening for common childhood vision issues, including those that may lead to amblyopia if not addressed promptly. The company also integrates cloud-based transmission, analysis, and storage of screening images, facilitating seamless coordination with Electronic Medical Records (EMR) systems for healthcare providers.

Better Walk

Seed Round in 2013
Better Walk Inc. is an innovative company that specializes in the design and development of crutches. Established in 2013 and headquartered in Atlanta, Georgia, the company aims to improve traditional crutch technology by alleviating pressure from the underarm area and minimizing direct force on the wrist of users. Better Walk's commitment to innovation is a fundamental aspect of its culture, which was further strengthened during its participation in the Zero To 510 accelerator in Memphis, where it secured early venture funding. In late 2014, the company shifted its focus to finalizing the Better Walk crutch, positioning itself for production and an anticipated product launch in early 2015.

Hapten Sciences

Seed Round in 2013
Hapten Sciences, Inc. is a privately-held biopharmaceutical company based in Memphis, Tennessee, established in 2010. The company focuses on the identification and development of early-stage products aimed at improving global health outcomes. One of its key innovations is PDC-APB, a vaccine designed to prevent contact dermatitis resulting from exposure to urushiol oil found in poison ivy, poison oak, and poison sumac. This product aims to provide patients with a solution to avoid allergic reactions without side effects, thereby contributing significantly to the well-being of individuals affected by these plants.

Better Walk

Seed Round in 2013
Better Walk Inc. is an innovative company that specializes in the design and development of crutches. Established in 2013 and headquartered in Atlanta, Georgia, the company aims to improve traditional crutch technology by alleviating pressure from the underarm area and minimizing direct force on the wrist of users. Better Walk's commitment to innovation is a fundamental aspect of its culture, which was further strengthened during its participation in the Zero To 510 accelerator in Memphis, where it secured early venture funding. In late 2014, the company shifted its focus to finalizing the Better Walk crutch, positioning itself for production and an anticipated product launch in early 2015.

Tidal Wave Technology

Seed Round in 2013
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Restore Medical Solutions

Series A in 2012
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Urova Medical

Seed Round in 2012
Urova Medical Inc. is a urological device company based in Memphis, Tennessee, focused on creating innovative solutions for stress urinary incontinence in women. Founded in 2012, the company developed its technology through a collaborative effort by biomedical engineering students at Johns Hopkins University, guided by expert physicians from the institution's renowned urological center. Urova Medical collaborates with urologists, gynecologists, and clinical researchers to create effective and convenient treatments for this condition. The company has also participated in the Zeroto510 Accelerator program, which is supported by local venture capital firms, further enhancing its development and outreach efforts.

Tidal Wave Technology

Seed Round in 2012
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Restore Medical Solutions

Seed Round in 2012
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Hapten Sciences

Seed Round in 2012
Hapten Sciences, Inc. is a privately-held biopharmaceutical company based in Memphis, Tennessee, established in 2010. The company focuses on the identification and development of early-stage products aimed at improving global health outcomes. One of its key innovations is PDC-APB, a vaccine designed to prevent contact dermatitis resulting from exposure to urushiol oil found in poison ivy, poison oak, and poison sumac. This product aims to provide patients with a solution to avoid allergic reactions without side effects, thereby contributing significantly to the well-being of individuals affected by these plants.

Urova Medical

Seed Round in 2012
Urova Medical Inc. is a urological device company based in Memphis, Tennessee, focused on creating innovative solutions for stress urinary incontinence in women. Founded in 2012, the company developed its technology through a collaborative effort by biomedical engineering students at Johns Hopkins University, guided by expert physicians from the institution's renowned urological center. Urova Medical collaborates with urologists, gynecologists, and clinical researchers to create effective and convenient treatments for this condition. The company has also participated in the Zeroto510 Accelerator program, which is supported by local venture capital firms, further enhancing its development and outreach efforts.

Veracity Medical

Seed Round in 2012
Veracity Medical Solutions, established in 2007 and headquartered in Collierville, Tennessee, is a medical device manufacturing company. It operates as a subsidiary of Arcamed, LLC. Veracity specializes in contract manufacturing, offering a comprehensive range of services from raw material to finished, packaged products. These include design, development, prototyping, custom, and special manufacturing services, ensuring clients can efficiently and accurately produce medical devices, surgical instrumentation, and implants.

Tidal Wave Technology

Seed Round in 2012
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

MB Innovations

Seed Round in 2011
MB Innovations, Inc. is a medical technology development company based in Memphis, Tennessee, founded in 2011. The company specializes in providing research, design, and development services for established firms, particularly in the musculoskeletal industry, on a fee-for-service basis. Its offerings encompass the entire development process, from initial concept to first-in-man surgical procedures, allowing clients to enhance their products and secure market presence. Additionally, MB Innovations aims to develop its own technologies and intellectual property, fostering new ventures and job creation in the region. The company's strategic location in Memphis offers access to significant research and development capabilities, supported by a team of experienced engineers and surgeon advisors, which facilitates a focused approach to product development and accelerates time to market.

Protein Discovery

Series C in 2008
Protein Discovery, Inc. is a life sciences company specializing in the development and commercialization of innovative sample preparation technologies for protein and peptide analysis via mass spectrometry. The company offers several key products, including the Gelfree 8100 fractionation system, which separates complex protein mixtures into liquid-phase molecular weight fractions, and the Passport 1200 sample preparation system, designed to enrich low molecular weight proteins and peptides while eliminating matrix interferences, facilitating high-throughput quantification. Additionally, Protein Discovery provides the PPS Silent Surfactant, a reagent that solubilizes membrane proteins and reduces detergent interference. The UPX universal protein extraction kit is also available for detergent extraction of proteins from cells and tissues. Catering to life science researchers and drug development scientists, Protein Discovery markets its products both through Agilent Technologies and online, reaching a global audience. Founded in 2001 in Knoxville, Tennessee, the company was originally named Qgenics Biosciences, Inc. before rebranding to its current name in 2004.

Biomimetic Therapeutics

Series C in 2005
BioMimetic Therapeutics is a biotechnology company focused on developing biologically active drug-device combination products that stimulate the body's natural tissue regenerative processes. Founded in 1999 and headquartered in Franklin, Tennessee, the company offers a range of products targeting various orthopedic and sports medicine conditions. These include Augment Injectable and Augment Rotator Cuff, which are designed for applications such as foot and ankle fusions, wrist fracture healing, and rotator cuff tear surgical treatment. Additionally, the Augment Tendinopathy Injection addresses injuries related to tendon overuse. Through its innovative approaches, BioMimetic Therapeutics aims to improve healing outcomes for patients with skeletal and associated tissue injuries.

Biomimetic Therapeutics

Series C in 2004
BioMimetic Therapeutics is a biotechnology company focused on developing biologically active drug-device combination products that stimulate the body's natural tissue regenerative processes. Founded in 1999 and headquartered in Franklin, Tennessee, the company offers a range of products targeting various orthopedic and sports medicine conditions. These include Augment Injectable and Augment Rotator Cuff, which are designed for applications such as foot and ankle fusions, wrist fracture healing, and rotator cuff tear surgical treatment. Additionally, the Augment Tendinopathy Injection addresses injuries related to tendon overuse. Through its innovative approaches, BioMimetic Therapeutics aims to improve healing outcomes for patients with skeletal and associated tissue injuries.

GTx

Series E in 2003
GTx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for stress urinary incontinence and prostate cancer. The company specializes in selective androgen receptor modulators (SARMs) and selective androgen receptor degraders, targeting conditions such as breast cancer and Duchenne muscular dystrophy. One of its notable product candidates is enobosarm GTx-024, which is undergoing Phase II clinical trials for patients with specific types of breast cancer and postmenopausal women suffering from stress urinary incontinence. Founded in 1997 and based in Memphis, Tennessee, GTx aims to advance medical solutions by leveraging new scientific approaches. In 2019, GTx was acquired by Oncternal Therapeutics in a reverse merger.

Biomimetic Therapeutics

Series B in 2003
BioMimetic Therapeutics is a biotechnology company focused on developing biologically active drug-device combination products that stimulate the body's natural tissue regenerative processes. Founded in 1999 and headquartered in Franklin, Tennessee, the company offers a range of products targeting various orthopedic and sports medicine conditions. These include Augment Injectable and Augment Rotator Cuff, which are designed for applications such as foot and ankle fusions, wrist fracture healing, and rotator cuff tear surgical treatment. Additionally, the Augment Tendinopathy Injection addresses injuries related to tendon overuse. Through its innovative approaches, BioMimetic Therapeutics aims to improve healing outcomes for patients with skeletal and associated tissue injuries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.